Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)
NCT01050634
·
clinicaltrials.gov ↗
COMPLETED
Status
980
Enrollment
INDUSTRY
Sponsor class
Conditions
Post Menopausal Women With Early Breast Cancer
Interventions
DRUG:
Aromasin (exemestane)
Sponsor
Pfizer